Results 241 to 250 of about 399,116 (301)

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond Y. H. Yap, Ka Lai Lee, Philip H. Li, Iris Y. K. Tang, Chak Sing Lau, Shirley C. W. Chan   +6 more
wiley   +1 more source

PDK1, associated with glycolytic metabolism, is a potential prognostic biomarker in osteosarcoma. [PDF]

PLoS One
Qi J, Liu S, Hu X, Luo X, Wang Y.
europepmc   +1 more source

Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma

Arthritis Care &Research, EarlyView.
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim, John Scott, Lauren Fisher, Lauren N. Smith, Willie Stewart, Adrianne Woods, Rob Smithwright, Diane Koher, Parastoo Aslanbeik, Aalok B. Shah, Brad Tibbils, Samantha I. Pitts, Ayse P. Gurses, Yushi Yang, Ana‐Maria Orbai, Antony Rosen, Laura K. Hummers, Scott L. Zeger, Ami A. Shah   +18 more
wiley   +1 more source

ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Ding J, Zou X, Huang X, Yu L, Hong H, Lin T.   +5 more
europepmc   +1 more source

Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis–Associated Interstitial Lung Disease

Arthritis Care &Research, EarlyView.
Objective A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M. Padilla, Robert Lafyatis, Kevin F. Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J. Kass   +13 more
wiley   +1 more source

Quantitative ctDNA Profiling of <i>RAS</i> Mutations as a Prognostic Biomarker in Metastatic Colorectal Cancer. [PDF]

Int J Mol Sci
Chibaudel B, Carola E, Mekranter H, Goyer P, Saget A, Oberlin O, Marijon H, Richa H, Iurisci I, Gervais H, Perez-Staub N, Dainese L, Pujol P, Toledano A, Bachet JB, de Gramont A.   +15 more
europepmc   +1 more source

Circulating Gene Expression Assay as a Diagnostic and Prognostic Biomarker for Pancreatic Neuroendocrine Tumors in MEN1.

J Clin Endocrinol Metab
van Vliembergen ENM, van Treijen MJC, van Leeuwaarde RS, Pieterman CRC, de Laat JM, Tesselaar MET, Valk GD.   +6 more
europepmc   +1 more source

GGTLC1 Is a Prognostic Biomarker in Renal Clear Cell Carcinoma. [PDF]

Int J Genomics
Li S, Shi L, Tao X, Yu G, Wang J.
europepmc   +1 more source

SDCBP2 promotes tumor progression and is a novel ferroptosis-related prognostic biomarker in lung adenocarcinoma. [PDF]

Front Immunol
Sun S, Gu Z, Yuan S, Zhang K, Liu W, Wei Z, Fan W, Wang Z, Zhao T, Tang M, Gao X, Zhang G, Li X, Pan X.   +13 more
europepmc   +1 more source

Integrative analysis identifies LHFPL6 as a CAF-specific prognostic biomarker in colorectal cancer. [PDF]

Clin Exp Med
Zheng X, Bai Y, Sun J, Yang Y, Lv X, Zhang X, Shi M, Zhao J, Shi D, Chen Z, Wang J, Yeo HY, Ma Y, He S, Peng M.   +14 more
europepmc   +1 more source